These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6016262)

  • 1. Sodium heparin neutralization and the anticoagulant effects of protamine sulfate.
    Adkins JR; Hardy JD
    Arch Surg; 1967 Feb; 94(2):175-7. PubMed ID: 6016262
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS; Rozkin MIa; Poberiĭ IA; Lindner DP
    Farmakol Toksikol; 1981; 44(1):80-5. PubMed ID: 7262304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interaction of the calcium salt of heparin with specific antagonists and ethacizine].
    Ushkalova EA; Petrov AD; Kremneva VF; Shcheglova NV
    Farmakol Toksikol; 1988; 51(6):53-6. PubMed ID: 3234542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the effect of varying protamine-to-heparin ratio on coagulation in vitro.
    Ho LTS; McVey MJ; Kuiper GJAJM; Gross PL; Karkouti K
    Br J Anaesth; 2021 Oct; 127(4):e128-e130. PubMed ID: 34334192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neutralization of low molecular weight heparin Kabi 2165 by protamine chloride].
    Harenberg J; Giese C; Knödler A; Zimmermann R; Schettler G
    Klin Wochenschr; 1986 Nov; 64(22):1171-5. PubMed ID: 3807263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative neutralization of lung- and mucosal-derived heparin by protamine sulfate using in vitro and in vivo methods.
    Lowary LR; Smith FA; Coyne E; Dunham NW
    J Pharm Sci; 1971 Apr; 60(4):638-40. PubMed ID: 5128383
    [No Abstract]   [Full Text] [Related]  

  • 7. [Protamine complexes with antithrombin III and heparin].
    Roszkowska W; Worowski K
    Acta Haematol Pol; 1982; 13(1-2):25-8. PubMed ID: 7180353
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of protamine of the prolonged response to intrapulmonary heparin.
    Wright CJ; Mahadoo J; Jaques LB
    Can J Surg; 1981 Mar; 24(2):130-2. PubMed ID: 7225967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of the heparin antagonist protamine chloride].
    Efimov VS
    Farmakol Toksikol; 1968; 31(5):601-4. PubMed ID: 5707736
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the anticoagulant action of heparin, protamine, and Polybrene in the activation of factor IX.
    Shanberge JN; Fukui H
    J Lab Clin Med; 1967 Jun; 69(6):927-37. PubMed ID: 6025496
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin neutralization by recombinant platelet factor 4 and protamine.
    Levy JH; Cormack JG; Morales A
    Anesth Analg; 1995 Jul; 81(1):35-7. PubMed ID: 7598278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of protamine sulfate on clot formation time and clot strength thromboelastography variables for canine blood samples.
    Bailey CJ; Koenigshof AM
    Am J Vet Res; 2014 Apr; 75(4):338-43. PubMed ID: 24669916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antiheparin action of berberine on the dog and human blood.
    Sabir M; Bhide NK
    Indian J Physiol Pharmacol; 1971 Jul; 15(3):97-100. PubMed ID: 5137671
    [No Abstract]   [Full Text] [Related]  

  • 15. Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model.
    Lee LM; Chang LC; Wrobleski S; Wakefield TW; Yang VC
    AAPS PharmSci; 2001; 3(3):E19. PubMed ID: 11741270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibition of heparin effects by protamine sulfate].
    GERENDAS M
    Orv Hetil; 1956 Jan; 97(5):113-8. PubMed ID: 13335127
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes.
    Cook JJ; Niewiarowski S; Yan Z; Schaffer L; Lu W; Stewart GJ; Mosser DM; Myers JA; Maione TE
    Circulation; 1992 Mar; 85(3):1102-9. PubMed ID: 1537108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density.
    Poon MC; Hurst RE; Rives MS
    Thromb Haemost; 1982 Apr; 47(2):162-5. PubMed ID: 7101237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro and ex-vivo neutralizing effect of protamine sulphate on the anticoagulant activity of a new low molecular mass heparin.
    Falkon L; Garí M; Gich I; Fontcuberta J
    Thromb Res; 1998 Jan; 89(2):79-83. PubMed ID: 9630311
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery.
    Yamamoto T; Wolf HG; Sinzobahamvya N; Asfour B; Hraska V; Schindler E
    Thorac Cardiovasc Surg; 2015 Aug; 63(5):397-403. PubMed ID: 26121380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.